Skip to content

Role of marma therapy in the treatment of job related stress

An anatomical study of urdhwajatrugata marma points and its role in the management of occupational stress : A single arm study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061025
Enrollment
90
Registered
2024-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F432- Adjustment disorders

Interventions

None listed

Sponsors

National Institute of Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinical findings suggestive of occupational stress will be the potential trial subjects. Patients in the age group 25-60 years of either sex. Patients assessed with low and moderate levels of stress according to Perceived Stress scale (PSS) and Work Stress Questionnaire.

Exclusion criteria

Exclusion criteria: Patients who are dependent and not willing to taper psychoactive drugs (sedatives). Patients who are suffering from acute systemic illness. Pregnant lady and lactating mothers, who have recent history (less than month) of abortion. Patient who are suffering from fluctuating hypertension and diabetes. Patient suffering from organic brain diseases. Patients suffering from any kind of major illness such as Malignancy, Cardiac disease, HIV, Tuberculosis etc. Patients having addiction (alcohol and narcotics).

Design outcomes

Primary

MeasureTime frame
Change in gradings of PSS & Work Stress QuestionnaireTimepoint: 1 month

Secondary

MeasureTime frame
Change in the EEG pattern & Salivary Cortisol LevelsTimepoint: 1 month

Countries

India

Contacts

Public ContactSonia Meend

National Institute of Ayurveda Deemed to be University, Jaipur

drskyadav4@gmail.com9413181445

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026